13F filing recap · Q3 2024
What did Torray Investment Partners buy in Q3 2024?
Reported stock-position changes between this filing and the previous one. US-listed stocks across every Torray account, including accounts that belong to no fund below.
Stock value
$714.58M
Positions
102
Estimated turnover
13.7%
Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.
Quarter in review
Torray Investment Partners opened new positions in Synopsys, Hewlett Packard Enterprise, CNA Financial, and several other companies, while exiting Biomarin Pharmaceutical, Cisco Systems, Merck, Price T Rowe Group, and Rolls-Royce. The firm substantially increased its stake in W. R. Berkley and Casey’s General Stores, and dramatically added to Broadcom. It trimmed Ansys and Lantheus Holdings substantially, and reduced Blackstone, Amgen, and O’Reilly Automotive.